TABLE 1.
Methodological quality of the included studies.
| Study | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | Total (0–10) |
| Counts et al. (2015) | — | + | − | + | − | − | − | + | + | + | + | 6 |
| Loenneke et al. (2015) | — | + | − | + | − | − | − | + | + | + | + | 6 |
| Loenneke et al. (2016) | — | + | − | + | − | − | + | + | + | + | + | 7 |
| Fatela et al. (2016) | — | + | − | + | − | − | − | + | + | + | + | 6 |
| Jessee et al. (2017) | — | + | − | + | − | − | − | + | + | + | + | 6 |
| Dankel et al. (2017) | — | + | − | + | − | − | − | + | + | + | + | 6 |
| Buckner et al. (2018) | — | + | − | + | − | − | − | + | + | + | + | 6 |
| Jessee et al. (2019) | — | + | − | NR | − | − | − | + | + | + | + | 5 |
| Ilett et al. (2019) | — | + | − | + | − | − | − | + | + | + | + | 6 |
| Singer et al. (2020) | — | − | − | + | − | − | − | + | + | + | + | 5 |
1 – Eligibility criteria specified; 2 – Random allocation; 3 – Concealed allocation; 4 – Groups similar at Baseline; 5 – Participant blinding; 6 – Therapist blinding; 7 – Assessor blinding; 8 – Adequate follow-up; 9 – Intention to-treat analysis; 10 - Between group comparisons; 11 – Point estimates and variability; NR: not reported.